Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 3/2011

01.06.2011

Histopathology of Lupus Nephritis

verfasst von: Konstantinos Giannakakis, Tullio Faraggiana

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

The spectrum of morphologic changes in lupus nephritis, either microscopic, ultrastructural, or immunohistological, closely reflects the great variety of immune complexes that are produced in the course of the disease. Every tissue component of the kidney can be affected, but glomeruli are the target structure in most patients. Several attempts have been made to correlate the clinical severity and the outcome of the nephritis with the pathologic features; the current classification and the six classes that resulted from an international study group are entirely based on glomerular changes. Major criteria of classification include the focal or diffuse involvement of the glomerulus, the site of hypercellularity, the site of immune complex deposition and the presence of active and/or sclerotic lesions. Even if less thoroughly investigated than the glomerulus, the interstitial compartment has revealed many interesting features as are vascular lesions, a common and often underestimated feature. Typing of subpopulation of lymphoid infiltrates supports the emerging evidence indicating that B cells are promoting autoimmunity in mechanisms other than autoAb secretion. Many aspects are still debated and/or poorly understood, such as the interpretation of the so-called “full house nephropathy” that closely mimic lupus nephritis in seronegative patients.
Literatur
1.
Zurück zum Zitat Klemperer P (1948) The pathogenesis of lupus erythematosus and allied conditions. Ann Intern Med 28:1–11PubMed Klemperer P (1948) The pathogenesis of lupus erythematosus and allied conditions. Ann Intern Med 28:1–11PubMed
2.
Zurück zum Zitat Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in sistemic lupus etythematosus visite. Kidney Int 65:521–530PubMedCrossRef Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in sistemic lupus etythematosus visite. Kidney Int 65:521–530PubMedCrossRef
3.
Zurück zum Zitat D’Agati V (2007) Renal diseases in systemic lupus erythematosus. In: Jennette JC, Olson JL, Schwartz M, Siva FG (ed) Pathology of the kidney, 6th edn. Lippincott Williams & Wilkins D’Agati V (2007) Renal diseases in systemic lupus erythematosus. In: Jennette JC, Olson JL, Schwartz M, Siva FG (ed) Pathology of the kidney, 6th edn. Lippincott Williams & Wilkins
4.
Zurück zum Zitat Mittal B, Rennke H, Singh AK (2005) The role of kidney biopsy in the management of lupus nephritis. Curr Opin Nephrol Hypertens 14:1–8PubMedCrossRef Mittal B, Rennke H, Singh AK (2005) The role of kidney biopsy in the management of lupus nephritis. Curr Opin Nephrol Hypertens 14:1–8PubMedCrossRef
6.
Zurück zum Zitat Muda AO, Feriozzi S, Rahimi S, Ancarani E, Faraggiana T (1999) Spatial arangement of subepithelial deposits in lupus and non lupus membranous nephropathy. Am J Kidney Dis 34:85–91PubMedCrossRef Muda AO, Feriozzi S, Rahimi S, Ancarani E, Faraggiana T (1999) Spatial arangement of subepithelial deposits in lupus and non lupus membranous nephropathy. Am J Kidney Dis 34:85–91PubMedCrossRef
7.
Zurück zum Zitat Schwartz MM1, Korbet SM, Katz RS3, Lewis EJ (2009) Evidence of concurrent immunopathological mechanisms determining the pathology of severe lupus nephritis. Lupus 18:149–158 Schwartz MM1, Korbet SM, Katz RS3, Lewis EJ (2009) Evidence of concurrent immunopathological mechanisms determining the pathology of severe lupus nephritis. Lupus 18:149–158
8.
Zurück zum Zitat Pickering MC, Botto M (2010) Are anti-C1q antibodies different from other SLE autoantibodies? Nat Rev Rheumatol (in press) Pickering MC, Botto M (2010) Are anti-C1q antibodies different from other SLE autoantibodies? Nat Rev Rheumatol (in press)
9.
Zurück zum Zitat Klemperer P (1940) Wire loops lesions. Arch Intern Med 66:1005 Klemperer P (1940) Wire loops lesions. Arch Intern Med 66:1005
10.
Zurück zum Zitat Frese-Schaper M, Zbaeren J, Gugger M, Monestier M, Frese S (2010) Reversal of established lupus nephritis and prolonged survival of New Zealand black and New Zealand white mice treated with the topoisomerase I inhibitor irinotecan. J Immunol 184:2175–2182PubMedCrossRef Frese-Schaper M, Zbaeren J, Gugger M, Monestier M, Frese S (2010) Reversal of established lupus nephritis and prolonged survival of New Zealand black and New Zealand white mice treated with the topoisomerase I inhibitor irinotecan. J Immunol 184:2175–2182PubMedCrossRef
11.
Zurück zum Zitat Hill GS, Delahousse M, Nochy D, Bariéty J (2005) Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int 68:2288–2297PubMedCrossRef Hill GS, Delahousse M, Nochy D, Bariéty J (2005) Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int 68:2288–2297PubMedCrossRef
12.
Zurück zum Zitat Austin HA, Muenz IR, Joyce KM, Antonovych TT, Ballow JE (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25:689–695PubMedCrossRef Austin HA, Muenz IR, Joyce KM, Antonovych TT, Ballow JE (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25:689–695PubMedCrossRef
13.
Zurück zum Zitat Hill GS, Delahousse M, Nochy D (2000) A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int 58:1160–1173PubMedCrossRef Hill GS, Delahousse M, Nochy D (2000) A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int 58:1160–1173PubMedCrossRef
14.
Zurück zum Zitat Mittal B, Hurwitz S, Rennke H, Singh AK (2004) New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J Kidney Dis 44:1050–1059PubMedCrossRef Mittal B, Hurwitz S, Rennke H, Singh AK (2004) New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J Kidney Dis 44:1050–1059PubMedCrossRef
15.
Zurück zum Zitat Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD (2000) Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35:904–914PubMedCrossRef Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD (2000) Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35:904–914PubMedCrossRef
16.
Zurück zum Zitat Nasr SH, D'Agati VD et al (2008) Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol 3:682–690PubMedCrossRef Nasr SH, D'Agati VD et al (2008) Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol 3:682–690PubMedCrossRef
17.
Zurück zum Zitat Sharman A, Furness P, Feehally J (2004) Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant 19:1420–1426PubMedCrossRef Sharman A, Furness P, Feehally J (2004) Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant 19:1420–1426PubMedCrossRef
18.
Zurück zum Zitat Jennette JC, Hipp CG (1985) C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 6:103–110PubMed Jennette JC, Hipp CG (1985) C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 6:103–110PubMed
19.
Zurück zum Zitat Chan OT, Madaio MP, Shlomchik MJ (1999) The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 169:107–121PubMedCrossRef Chan OT, Madaio MP, Shlomchik MJ (1999) The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 169:107–121PubMedCrossRef
20.
Zurück zum Zitat Papadimitraki ED, Choulaki CH, Koutala E et al (2006) Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus. Implications for the induction and maintenance of the autoimmune process. Arthritis Rheum 54:3601–3611PubMedCrossRef Papadimitraki ED, Choulaki CH, Koutala E et al (2006) Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus. Implications for the induction and maintenance of the autoimmune process. Arthritis Rheum 54:3601–3611PubMedCrossRef
21.
Zurück zum Zitat Hayakawa S, Nakabayashi K, Karube M et al (2006) Tubulointerstitial immune complex nephritis in a patient with systemic lupus erythematosus: role of peritubular capillaritis with immune complex deposits in the pathogenesis of the tubulointerstitial nephritis. Clin Exp Nephrol 10:146–151PubMedCrossRef Hayakawa S, Nakabayashi K, Karube M et al (2006) Tubulointerstitial immune complex nephritis in a patient with systemic lupus erythematosus: role of peritubular capillaritis with immune complex deposits in the pathogenesis of the tubulointerstitial nephritis. Clin Exp Nephrol 10:146–151PubMedCrossRef
22.
Zurück zum Zitat Nochy D, Daugas E, Droz D et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507–518PubMed Nochy D, Daugas E, Droz D et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507–518PubMed
Metadaten
Titel
Histopathology of Lupus Nephritis
verfasst von
Konstantinos Giannakakis
Tullio Faraggiana
Publikationsdatum
01.06.2011
Verlag
Humana Press Inc
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 3/2011
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-010-8207-1

Weitere Artikel der Ausgabe 3/2011

Clinical Reviews in Allergy & Immunology 3/2011 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.